Life science companies developing bird flu vaccines are gaining attention as the avian influenza subtype H5N1 becomes an increasing concern. The United States is in the midst of an H5N1 bird flu outbreak that began in February 2024 and is now threatening the nation’s poultry and cattle industries.

The CDC has sequenced bird flu viruses from people in Nevada and Wyoming, and the Trump Administration has released a strategy for reducing egg prices

A new low-cost sensor that detects airborne H5N1 avian flu in under five minutes sounds mighty good as bird flu continues to spread, infecting 70 people in the United States in the past 11 months, the Centers for Disease Control and Prevention in Atlanta has confirmed.

The US government is considering bird flu vaccines to prevent the mass culling of infected chickens, which has driven egg prices to nearly $6 per dozen.

As bird flu outbreaks continue to affect animals, experts answer questions about keeping pets and their owners healthy

The move has been delayed in part because of concerns it could jeopardize chicken exports worth billions of dollars a year.

Vaccines could be a key means of suppressing bird flu and avoiding the slaughter of millions of chickens, which is blamed for egg prices averaging nearly $5 a dozen.

Chicken meat producers remain the most resistant to vaccines because of concerns they could harm meat exports, which totaled nearly $4.7 billion last year.